Company: AEMD
Filing Date: 2025-06-26
Form Type: 10-K
Source: 0001683168-25-004780
Chunk: 781

Company: AETHLON MEDICAL INC
Filing Date: 2025-06-26
Form: 10-K
Item: Item 4
Chunk 781
---
138.9%

    Risk-free interest rate

    4.07%

    4.02%

    2.20%

    Expected dividend rate

    0.00%

    0.00%

    0.00%

    (7)
    TSR is determined based on the value of an initial fixed investment of $100 on March 31, 2022. Cumulative TSR is calculated by dividing the sum of the cumulative amount of dividends for the measurement period, assuming dividend reinvestment, and the difference between the Company’s share price at the end and the beginning of the measurement period by the Company’s share price at the beginning of the measurement period.

    (8)
    Net loss attributable to Aethlon as reported in the Company’s consolidated financial statements for the applicable year.

 75 

Required Narrative Disclosure to Pay Versus
Performance Table

In accordance with Item 402(v) of Regulation
S-K, we are providing the following descriptions of the relationships between information presented in the Pay Versus Performance table
above.

Compensation Actually Paid and Net Income
Loss

Because the Company is a pre-commercial stage
company, we had no revenue during the periods presented, other than revenue associated with government contracts and grants. Consequently,
we do not use net income (loss) as a performance measure in our executive compensation program. Moreover, as a pre-commercial
stage company with limited revenue, we do not believe there is any meaningful relationship between our net loss and compensation
actually paid to our NEOs during the periods presented.

Compensation Actually Paid and Cumulative TSR

The chart below shows the relationship between
the compensation actually paid to our PEOs and the average compensation actually paid to our non-PEO NEOs, on the one hand, to the Company’s
cumulative TSR over the three years presented in the table, on the other.

All information provided above under the “Item
402(v) Pay Versus Performance” heading will not be deemed to be incorporated by reference into any filing of the Company under the
Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date hereof and
irrespective of any general incorporation language in any such filing, except to the extent the Company specifically incorporates such
information by reference.

 76 

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR
INDEPENDENCE

The